Quest Diagnostics (DGX) Shares Issued (2009 - 2026)

Quest Diagnostics has disclosed Shares Issued across 18 years of filings, most recently posting $65.0 million for Q1 2026.

• Shares Issued for Q1 2026 came in at $65.0 million, up 124.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $115.0 million (up 27.78% YoY), and the FY2025 annual result was $79.0 million, up 8.22% from the prior year.
• Shares Issued came in at $65.0 million for Q1 2026 at Quest Diagnostics, up from $18.0 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $65.0 million in Q1 2026 to a low of $10.0 million in Q1 2022.
• The 5-year median for Shares Issued is $21.0 million (2024), against an average of $24.2 million.
• Peak annual rise in Shares Issued reached 150.0% in 2023, while the deepest fall reached 62.07% in 2023.
• Quest Diagnostics' Shares Issued stood at $27.0 million in 2022, then slumped by 55.56% to $12.0 million in 2023, then surged by 75.0% to $21.0 million in 2024, then fell by 14.29% to $18.0 million in 2025, then soared by 261.11% to $65.0 million in 2026.
• The last three Shares Issued figures came in at $65.0 million (Q1 2026), $18.0 million (Q4 2025), and $19.0 million (Q3 2025), per Business Quant data.